Background-Recent studies suggest that the hematopoietic and cardiac lineages have close ontogenic origins, and that an early mesodermal cell population has the potential to differentiate into both lineages. Studies also suggest that specification of these lineages is inversely regulated. However, the transcriptional networks that govern the cell fate specification of these progenitors are incompletely defined. Methods and Results-Here, we show that Nkx2-5 regulates the hematopoietic/erythroid fate of the mesoderm precursors early during cardiac morphogenesis. Using transgenic technologies to isolate Nkx2-5 expressing cells, we observed an induction of the erythroid molecular program, including Gata1, in the Nkx2-5-null embryos. We further observed that overexpression of Nkx2-5 with an Nkx2-5-inducible embryonic stem cell system significantly repressed Gata1 gene expression and suppressed the hematopoietic/erythroid potential, but not the endothelial potential, of the embryonic stem cells. This suppression was cell-autonomous, and was partially rescued by overexpressing Gata1. In addition, we demonstrated that Nkx2-5 binds to the Gata1 gene enhancer and represses the transcriptional activity of the Gata1 gene. Conclusions-Our results demonstrate that the hematopoietic/erythroid cell fate is suppressed via Nkx2-5 during mesodermal fate determination, and that the Gata1 gene is one of the targets that are suppressed by Nkx2-5. (Circulation. 2011; 123:1633-1641.)
P revious studies support the hypothesis that multipotent progenitors give rise to diverse lineages in the developing embryo. Examples of multipotent progenitors include the mesoangioblast (which parents hematopoietic, smooth muscle, endothelial, and cardiomyocyte lineages 1 ), hemangioblasts (a common progenitor of hematopoietic and endothelial lineages 2 ), and multipotent cardiac progenitor cells, which have the potential to differentiate into all 3 major cell types of the heart, including cardiac myocytes, endothelial cells, and smooth muscle cells. 3 Although the multipotent cardiac progenitor cells express Nkx2-5, the transcriptional networks that govern the fate of these multipotent progenitors remain incompletely defined. Our previous analysis of the cardiac cell lineage demonstrated that the Nkx2-5-expressing progenitors transiently express hematopoietic markers, supporting the notion that there is a bipotential stage in early mesoderm during which cardiac and hematopoietic markers are coexpressed. 4
Clinical Perspective on p 1641
Nkx2-5 is one of the earliest transcription factors expressed in multipotent cardiac progenitor cells during vertebrate heart development. Global elimination of Nkx2-5 in mice results in severe growth retardation, perturbed cardiac morphogenesis, and embryonic lethality at approximately embryonic day (E) 9.5 to 10.0. 5, 6 However, conditional elimination of Nkx2-5 in cardiac myocytes results in viable neonates that have progressive cardiac dysfunction. 7 Although these studies highlight the significance of Nkx2-5 transcriptional activity during cardiac morphogenesis, they also support the notion that the embryonic lethality in mice with global disruption of Nkx2-5 is due in part to perturbations of other lineages, because these null embryos have severe anemia, angiogenic defects, and the absence of endocardial cushion. 5, 6 These results further indicate that the functional role of Nkx2-5 during embryogenesis is not restricted to promoting cardiac muscle development.
Gata factors have been grouped on the basis of their expression and role during development. Gata1, Gata2, and Gata3 are involved in hematopoietic commitment, erythrocyte differentiation, and progenitor cell proliferation and T-cell differentiation, respectively, whereas Gata4, Gata5, and Gata6 play important roles during cardiac morphogenesis. 8 Gata1 is the first transcription factor shown to be important for the genesis of the erythroid lineage early during embryogenesis. 9 Targeted disruption or overexpression of Gata1 results in embryonic lethality caused by anemia, suggesting that Gata1 dosage levels are critically regulated during erythropoiesis. Previous studies have identified the essential regulatory elements for Gata1 expression in erythroid lineages, and have established that Gata1 gene expression is partly regulated by Gata1 itself. 9 Recent fate mapping studies in zebrafish defined that the hematopoietic and cardiac fates from lateral plate mesoderm are inversely regulated. 10 Although the previous study describes SCL and ER71 as transcription factors that promote the hematopoietic fate and repress the cardiac fate, the cardiac transcription factor that functions in a reciprocal fashion is yet to be defined.
In the present study, we define an Nkx2-5-mediated mechanism that coordinately regulates the cellular fate of mesoderm progenitors. Using genetic mouse models and molecular analyses of Nkx2-5-expressing cells, we observed an induction of the erythroid molecular program, including Gata1, in the progenitors isolated from the developing Nkx2-5-null hearts. We also demonstrated that overexpression of Nkx2-5, using an inducible embryonic stem cell/ embryoid body (ES/EB) system, significantly repressed the hematopoietic/erythroid program, but not the endothelial program, in a cell-autonomous fashion. This repression was partially rescued by Gata1 overexpression. Using a reporter gene assay, we observed that Nkx2-5 represses the Gata1 promoter activity by binding to the Gata1 gene enhancer. Our studies support a model for Nkx2-5-dependent regulation of Gata1 gene expression in the multipotent progenitors. This novel and previously undefined functional role for Nkx2-5 will complement and extend our understanding of the mechanisms by which cardiac lineages are determined in mesodermal precursors.
Methods

Transcriptional Assays
The 3.9-kb Gata1 hematopoietic enhancer and minigene were previously described. 11 All transcriptional assays were performed in the K562 cell line. Specific conditions can be found in online-only Data Supplement.
Generation of Nkx2-5-Inducible Embryonic Stem Cell/Embryoid Body System
Generation and maintenance of inducible Nkx2-5 (iNkx2-5) cells, formation and differentiation of EBs were carried out as described. 12, 13 Doxycycline (0.5 g/mL) was added to induce Nkx2-5 expression for 24 hours at the start of day 3. EBs were washed and fed fresh medium on day 4 and further cultured for an additional 2 days to evaluate the effect of Nkx2-5 on hematopoietic commitment. To monitor the effect of Nkx2-5 on hematopoietic/erythroid differentiation, EBs were treated with doxycycline for 48 hours beginning on day 4 of EB formation. EBs were collected on day 6 and processed for isolation of RNA and fluorescence-activated cell sorter (FACS) analyses or for methylcellulose assays.
Statistical Analysis
Data represent the average of Ͼ3 replicates (replicate numbers are indicated in the text) and SD. Significance was tested by the Mann-Whiney U test for 2 groups and Kruskal-Wallis test, with the Dunn multiple-comparison test for Ͼ2 groups. For colony counts, normalizing transformation (square root) was done before statistical analysis. The above analyses were done with Prism 4.0 software (GraphPad Software). Quantitative reverse-transcription polymerase chain reaction (RT-PCR) data were analyzed by the RQ analysis algorithm (ABI). Error bars indicate the 99% confidence interval.
Results
Induction of the Erythroid Molecular Program in the Nkx2-5-Null Heart
We have previously generated a transgenic mouse model using an Nkx2-5 cardiac-specific enhancer to direct enhanced yellow fluorescent protein (EYFP) reporter expression to the developing heart. This transgenic model recapitulates endogenous Nkx2-5 expression early during heart development. 4 Transcriptome analyses from EYFP-positive embryonic cells revealed that the cardiac transcriptional regulators are enriched in this population. 4 The analysis further revealed that the progenitors isolated from the E7.75 cardiac crescent have transient expression of genes that are essential for erythroid differentiation. These genes were downregulated at later stages of heart development (E9.5). 4 These data suggested that cardiac progenitors coexpress erythroid genes but that cardiac transcriptional regulators promote cardiac differentiation by negatively regulating the gene expression of the erythroid program.
To address the functional role of Nkx2-5 in this regulatory pathway, we examined the molecular signature of the EYFPexpressing cells in the presence or absence of Nkx2-5. We crossed Nkx2-5 ϩ/Ϫ female and Nkx2-5-EYFP transgenic Nkx2-5 ϩ/Ϫ male mice, and isolated EYFP-positive cells from the developing hearts of wild-type (Nkx2-5 ϩ/ϩ ) or Nkx2-5null (Nkx2-5 Ϫ/Ϫ ) progeny. Persistent EYFP expression was observed in the heart field of both Nkx2-5 ϩ/ϩ and Nkx2-5 Ϫ/Ϫ embryos ( Figure 1A) .
The EYFP ϩ cells from individual wild-type and null littermate embryos at E8.0 were sorted with the use of flow cytometry and processed for gene expression analysis by quantitative RT-PCR ( Figure 1B ). We observed that Nppa, a direct downstream target of Nkx2-5, 5, 14 was downregulated in the Nkx2-5 Ϫ/Ϫ cardiac progenitor cells, whereas the hematopoietic markers Gata1, Eklf, and Nfe2 were upregulated ( Figure 1B) . Thus, our analysis demonstrated increased expression of hematopoietic markers in Nkx2-5 Ϫ/Ϫ progenitors.
Overexpression of Nkx2-5 Represses Erythroid Differentiation in ES Cells
We used the ES/EB system to enhance our understanding of the role of Nkx2-5 regulating hematopoietic fate, because it is a powerful model system for the study of cellular fate specification and lineage commitment. 15 Previous studies have demonstrated that the commitment of EBs to a hematopoietic fate occurs between days 2.75 and 3.75, whereas hematopoietic differentiation occurs between days 4 and 6. 16 Moreover, our laboratory and others have demonstrated that Nkx2-5 expression is observed as early as in 3.5 days of EB differentiation, and is robustly expressed by day 5. [17] [18] [19] Because the onset of Nkx2-5 expression (day 3.5) coincides with the divergence of hematopoietic and cardiac fate in the ES/EB system, we hypothesized that Nkx2-5 has a functional role in this process. To test this hypothesis, we generated an iNkx2-5 cell line, an ES cell line that expresses Nkx2-5 in response to doxycycline. 12 Nkx2-5 was induced for 24 hours from day 3 to 4 EBs to examine the effect on hematopoietic commitment or for 48 hours from day 4 to 6 EBs to evaluate the effect on hematopoietic differentiation, and the respective EBs were collected on day 6 ( Figure 2A ).
Using quantitative RT-PCR, we observed that genes involved in erythroid differentiation are downregulated in doxycycline-induced EBs with both treatment schedules (Figure 2B) . In contrast, a downstream target gene of Nkx2-5 in cardiac development, Nppa, was significantly upregulated ( Figure 2B ). Therefore, Nkx2-5 does not act as a nonspecific repressor of gene expression, but specifically inhibits the erythroid program in doxycycline-induced EBs. The reciprocal response of these genes to overexpression and loss of function of Nkx2-5 supports the notion that Nkx2-5 inhibits the erythroid program while promoting cardiac development ( Figure 1B and 2B).
Using FACS analysis, we then examined the cell surface markers of iNkx2-5 cells. Control and doxycycline-induced EBs were dissociated at day 6 of differentiation and analyzed for c-kit and CD41 (hematopoietic progenitor markers) versus c-kit and CD45 (more committed hematopoietic cell markers) expression. When Nkx2-5 was induced from day 3 to day 4, we identified no hematopoietic progenitors (c-kit ϩ / CD41 ϩ ) or mature hematopoietic cells (c-kit ϩ /CD45 ϩ ; data not shown). When Nkx2-5 was overexpressed between days 4 and 6 of differentiation, both early and late hematopoietic progenitors (c-kit ϩ /CD41 ϩ and c-kit ϩ /CD45 ϩ ) were detectable, but significantly reduced in the presence of Nkx2-5 ( Figure 2C and 2D).
To further evaluate whether Nkx2-5 may also play a role in hematopoietic/erythroid differentiation of ES cells, we used colony-forming cell assays. Untreated day 6 EBs were trypsinized, and 5ϫ10 4 cells were plated on methylcellulose plates for hematopoietic colony formation in the presence or absence of doxycycline. Colonies were quantified after 6 days of culture. Few or no colonies were formed from 2 independent clones of iNkx2-5 cells when doxycycline was added to the methylcellulose, whereas erythroid, granulocyte-macrophage, and mixed colonies were detected when cultured in the absence of doxycycline ( Figure 2E and 2F). To determine whether Nkx2-5 overexpression specifically affected the erythroid program or has a broader role in hematopoiesis, day 4 EBs were induced for 48 hours (with variable concentrations of doxycycline) and then plated on methylcellulose in the absence of doxycycline ( Figure 2G ). Induction of Nkx2-5 expression in EBs at this earlier time of hematopoietic development resulted in a preferential repression of erythroid colony formation in a dose-dependent fashion ( Figure 2G ). The reduction of erythroid colonies was readily observed at the lowest dose of doxycycline (0.1 g/mL) examined, whereas formation of other colonies was less affected. Collectively, our data support the hypothesis that Nkx2-5 either directly or indirectly represses the expression of genes that are essential for erythroid specification and differentiation during development.
Overexpression of Nkx2-5 Does Not Repress Endothelial Differentiation in Embryonic Stem Cells
Because previous studies have suggested that hematopoietic and endothelial cells as well as cardiomyocyte and endothelial cells are derived from common progenitors, 16, 17, 20 we examined whether overexpression of Nkx2-5 also repressed the endothelial specification/differentiation of EBs. Day 4 EBs were induced with doxycycline or left uninduced for 48 hours, dissociated on day 6, and analyzed with FACS. Cells were doubly stained with combinations of antibodies against Flk-1, VE-cadherin, and CD31 (platelet endothelial cell adhesion molecule [PECAM]) to identify endothelial lineages. We observed that the induction of Nkx2-5 expression did not repress the endothelial program ( Figure 3A and 3B) , in contrast to the strong repression of hematopoietic/erythroid potential ( Figure 2 ). These results indicated that overexpression of Nkx2-5 specifically repressed hematopoietic/erythroid potential, but not the endothelial/vascular potential, of the differentiating EBs.
To further confirm these results, we used morphological techniques of serial sections. An antibody against CD31/ PECAM as well as hematoxylin and eosin staining were used to identify vessel-like structures (VLSs) and blood cells, respectively. As shown in Figure 3C , CD31/PECAM-positive VLSs were detected in both induced and noninduced EBs, but VLSs containing blood-like cells were detected almost exclusively in the noninduced EBs. Quantification of VLSs from both doxycycline-treated and untreated EBs revealed that only 7% of the VLSs contained blood-like cells in the Nkx2-5-induced EBs, whereas Ϸ60% of the VLSs had blood components in the noninduced EBs ( Figure 3D ). These data further confirmed that the overexpression of Nkx2-5 nega-tively regulated the hematopoietic/erythroid program without affecting the endothelial differentiation of progenitor cells.
Nkx2-5 Represses Hematopoietic Differentiation of Embryonic Stem Cells Cell-Autonomously
We examined whether repression of hematopoietic differentiation by Nkx2-5 is mediated by secreted factors or is a cell-autonomous effect. We mixed iNkx2-5 cells with E14green fluorescent protein (GFP) cells, an ES cell line that constitutively expressed the GFP protein, 21 and differentiated . ␤-Actin (Actb) is a loading control. B, Quantitative RT-PCR analysis of doxycycline-treated and untreated embryoid bodies (EBs; nϭ6) revealed that overexpression of Nkx2-5 significantly suppressed erythroid genes, including Gata1. In contrast, an Nkx2-5 downstream target gene, Nppa, was significantly upregulated. Bars represent 99% confidence interval (nϭ3). C, Fluorescence-activated cell sorter (FACS) analysis of cell surface markers of differentiating EB cells. EBs were treated (Doxϩ) or left untreated (DoxϪ) from day 4 to 6 and analyzed for hematopoietic markers on day 6. For early and late hematopoietic markers, combinations of c-kit/CD41 and c-kit/CD45, respectively, were used. The experiment was repeated 5 times, and representative data are shown. D, Quantification of the FACS data in C (analyzed by Mann-Whitney U test; nϭ5). E and F, Induction of Nkx2-5 expression suppresses hematopoietic/erythroid colony formation. E, Day 6 EBs from 2 different clones of iNkx2-5 cells were isolated and plated in complete methylcellulose in the absence (control) or presence (induced) of doxycycline (analyzed by Mann-Whitney U test after normalizing transformation; nϭ3). Note that little or no colony formation was observed in the presence of doxycycline, whereas erythroid, granulocyte-macrophage (GM), and mixed colonies were detected when EBs were cultured without doxycycline. G, Induction of Nkx2-5 expression from day 4 to 6 with lower concentrations of doxycycline preferentially repressed erythroid colony formation. Day 4 EBs with or without 48-hour induction with the specified concentration of doxycycline were dissociated, and equal numbers of cells were plated in methylcellulose without doxycycline. Note the significant repression of erythroid (ery) colony formation compared with the GM and mixed colonies (analyzed by Mann-Whitney U test after normalizing transformation; nϭ3). Figure 4A) . We analyzed the EBs on day 6 of induction. Green fluorescent protein-positive and -negative cells were isolated and analyzed for CD41 expression (as a measure of hematopoiesis) with FACS. When iNkx2-5 cells and E14-GFP cells were mixed at a 50:50 ratio, the hematopoietic potential of iNkx2-5 cells (GFP-negative population) was suppressed after treatment with doxycycline ( Figure 4B ; compare a and c). In contrast, the hematopoietic potential of E14-GFP cells was not significantly altered in the same culture ( Figure 4B ; compare b and d). To address whether a putative soluble factor is limiting in the culture, we mixed the cells at a 75:25 ratio, but the hematopoietic potential of E14-GFP cells still was not affected ( Figure 4C) . Thus, these data demonstrated that Nkx2-5 repressed hematopoietic differentiation of iNkx2-5 cells in a cell-autonomous fashion. . Nkx2-5 suppresses hematopoiesis in a cell-autonomous fashion. A, Inducible Nkx2-5 (iNkx2-5) cells were mixed with wild-type E14 -green fluorescent protein (GFP) cells and induced to form embryoid bodies (EBs). Cells were either treated with doxycycline from day 2 to 4 or left untreated. On day 6, cells were dissociated and analyzed by fluorescence-activated cell sorter (FACS). B and C, Representative FACS profiles from experiments in which iNkx2-5 cells and E14-GFP cells were mixed at a 50:50 (B) or 75:25 (C) ratio. Note that in both conditions, the CD41 ϩ cells originated from iNkx2-5 cells (CD41 ϩ , GFP Ϫ population) were reduced on Nkx2-5 induction (compare a and c), whereas those that originated from E14-GFP cells (CD41 ϩ , GFP ϩ population) remained unchanged (compare b and d).
EBs in the presence or absence of doxycycline (
Nkx2-5 Represses Gata1 Transcriptional Activity
Gata1 is an essential transcription factor for the genesis of the erythroid lineage early during embryogenesis. 22 Because Gata1 and its downstream targets (eg, Eklf1 and Nfe2) 23 were dysregulated with loss of function or overexpression of Nkx2-5, we hypothesized that the Gata1 gene is regulated by Nkx2-5. Previous studies established that the 3.9-kb upstream sequence is essential for Gata1 expression in both primitive and definitive erythroid cells ( Figure 5A ). 11, 24, 25 Four elements, including the Gata-1 hematopoietic enhancer (G1HE) region, 2 proximal GATA-binding sites, and the CACCC motif, are necessary for Gata1 expression, and the minigene construct ( Figure 5A ) that contains these 4 elements recapitulates Gata1 gene expression in primitive erythroid cells. 11 When the 3.9-kb reporter plasmid was cotransfected with increasing amounts of the Nkx2-5 expression vector, the luciferase activity was repressed in a dose-dependent fashion ( Figure 5B ). The minigene construct responded similarly to Nkx2-5 ( Figure 5C ). Two sequences show homology to the Nkx binding site (NKE) within the minigene construct ( Figure 5A ). Deletion of the proximal double GATA site and NKE (del1) reduced the baseline activity of the promoter but did not change its response to Nkx2-5 ( Figure I in the online-only Data Supplement and Figure 5D ). In contrast, when G1HE was deleted (del2), the repression by Nkx2-5 was abolished ( Figure 5E) . Similarly, the point mutation of the distal NKE (mut1), but not the proximal NKE (mut2), significantly reduced the response to Nkx2-5 ( Figure II in the online-only Data Supplement). Thus, our results demonstrated that the 233-bp fragment harboring G1HE and NKE therein mediates the repressive activity of Nkx2-5. The repressive activity of Nkx2-5 was not a general inhibition of transcription because the promoter of Nppa, a known target of Nkx2-5, was activated Ͼ100-fold in the same system ( Figure 5F ).
Next, we determined whether Nkx2-5 directly binds to the Gata1 gene. We generated a DNA binding mutant of Nkx2-5 (leucine 176 to proline; L176P) that functions as a dominant negative inhibitor of Nkx2-5. 26 Transient transfection assay demonstrated that the L176P DNA binding mutant did not inhibit the activity of the 3.9-kb upstream region or the Gata1 minigene, although the protein was expressed at levels similar to the wild-type ( Figure 5G and 5H ). Next, we examined whether Nkx2-5 binds to the G1HE region using chromatin immunoprecipitation assay. A specific band corresponding to the G1HE and Nppa regulatory region was amplified from immunoprecipitates using the Nkx2-5 antibody but not the control immunoglobulin ( Figure 5I and 5J ). Furthermore, electrophoretic mobility shift assay using nuclear extracts prepared from iNkx2-5 cells induced for 6 hours (to ensure that there is no secondarily induced genes) identified a specific shift that appears only in the induced extract ( Figure III in the online-only Data Supplement). Collectively, our results support the conclusion that Nkx2-5 binds to the distal NKE and represses Gata1 gene transcription. Figure 5 . Nkx2-5 represses Gata1 promoter activity. A, Schematic of the 3.9 kb upstream region of the Gata1 gene and reporter plasmids used in the transcriptional assays. Two GATA binding sequences (underlined) and an Nkx2-5 consensus sequence (bold) within the G1HE are indicated. B through G, Transcriptional assay in K562 cells reveals a dose-dependent repression of luciferase activity by Nkx2-5 using the 3.9-kb erythroid enhancer (B) or the minigene (C). Deletion (del) 2 (E) but not deletion 1 (D) abolished the response to Nkx2-5. F, Nppa, a downstream target of Nkx2-5, was activated under the same condition. G, The L176P mutation of Nkx2-5 in the homeodomain impairs its activity to repress Gata1 transcription. B through G were analyzed by the Kruskal-Wallis test (nϭ3). *PϽ0.05 vs the sample without the Nkx2-5 expression vector (0 ng). Bars without an asterisk were not significant. H, Western blot analysis from the transfected samples (500-ng vector) shows that wildtype protein and the L175P mutant are expressed at equivalent levels. I and J, Chromatin was isolated from embryoid bodies (EBs) of inducible Nkx2-5 cells induced for 24 hours with doxycycline and analyzed by chromatin immunoprecipitation assay. I, Nkx2-5 antibody, but not control IgG, precipitated genomic fragments containing the Gata1 and the Nppa promoter region. J, Quantification of the band intensity by quantitative polymerase chain reaction (analyzed by Wilcoxon signed rank test; nϭ4).
Repression of Hematopoietic Genes by Nkx2-5 Is Rescued by Overexpression of Gata1
To determine whether Gata1 is a direct downstream target of Nkx2-5, we performed a rescue experiment ( Figure 6A ). We used an inducible lentiviral vector to express GFP alone (control) or the Gata1 and GFP proteins in response to doxycycline. Thus, in this system, expression of both Nkx2-5 and Gata1 was regulated by the tetracycline-responsive promoter. iNkx2-5 cells were infected, expanded, sorted for GFP-positive cells and were differentiated to form EBs. Embryoid bodies were treated with 1.0 g/mL doxycycline from day 4 to 6 of induction and analyzed on day 6 for expression of CD41. In this experimental paradigm, all cells treated with doxycycline expressed Nkx2-5 ( Figure 6A,  groups b and d [red] ). Sorting and analyzing GFP-positive cells allowed us to examine only the infected cells with the control GFP virus (group b [dark green]) or the Gata1-GFP virus (group d [light green]). Fluorescence-activated cell sorter analysis demonstrated that 22% to 28% of uninduced groups (groups a and c) were positive for CD41, whereas group b, which expressed Nkx2-5 and GFP, contained on average 12.0% of CD41-positive cells ( Figure 6C ). Group d, which expressed Nkx2-5, GFP, and Gata1, contained on average 21.7% of CD41-positive cells, indicating that Gata1 partially rescued the Nkx2-5-mediated repression (as measured by CD41 expression; Figure 6C ). Congruent with the FACS profile, the gene expression profile of the sorted cells demonstrated a 15-fold increase in the Gata1 transcript and between a 2-and 12-fold increase in erythroid-specific genes such as beta major globin, embryonic globin, Nfe2, Lmo2, Klf1, and Scl ( Figure 6D) . Thus, our data demonstrated that overexpression of Gata1 at least partially rescued the inhibitory effect of Nkx2-5 on hematopoiesis.
Discussion
Multipotent cardiac progenitors express Nkx2-5 and generate diverse lineages that contribute to heart formation during embryogenesis. Although intense interest has focused on the genesis of the cardiac progenitors, the molecular networks that govern cellular fate specification remain incompletely defined. In the present study, we used an array of technologies to define the functional role of Nkx2-5 and fate specifi- cation. Our studies have advanced this field through several significant findings. First, using a genetic marking method, we observed that genes involved in erythroid differentiation are upregulated in the Nkx2-5 Ϫ/Ϫ progenitors. This finding led us to hypothesize that an undescribed function of Nkx2-5 is to suppress noncardiac lineages during embryogenesis. This hypothesis was tested with the ES/EB system, which mirrors embryonic development and has been used as a model system to analyze the fate of cell lineages. We showed that overexpression of Nkx2-5 represses hematopoietic/erythroid differentiation in ES/EBs as assessed by 4 independent measures: gene expression pattern, expression of cell surface markers, morphology, and colony-forming activity. We further demonstrated that repression of hematopoietic/erythroid differentiation is a cell-autonomous effect. Interestingly, our cellular and immunohistochemical analyses revealed that overexpression of Nkx2-5 specifically and significantly repressed the hematopoietic/erythroid program, but not the endothelial potential, of the differentiating EBs. From this observation, we hypothesize that Nkx2-5 does not function at the level of the hemangioblast, the putative common precursor for hematopoietic and endothelial cells. Rather, our studies suggest that Nkx2-5 may function distinctly to maintain 1 lineage (endothelial or cardiomyocyte) by repressing gene expression associated with other (ie, hematopoietic) lineages.
Whether a common progenitor for cardiac and hematopoietic lineages exists has been controversial. Although analyses based on colony-forming assays show that hematopoietic and cardiac lineages arise from distinct mesodermal progenitors, 17, 27 several lines of evidence suggest that there is a stage during development when mesodermal cells have multilineage potential and can generate blood or cardiac cells, depending on the environment. 4,10,28 For example, chick tissues from the posterior primitive streak, an area outside the heart field, can be induced to differentiate into cardiac myocytes by coculturing with anterior endoderm tissue. This takes place at the expense of the blood lineage. 28 In the zebrafish cloche mutant, specification of endothelial and hematopoietic lineages is impaired in the anterior lateral plate mesoderm, and in turn, the cardiac lineage is expanded. 10, 29 Similar findings have been obtained in the ER71 Ϫ/Ϫ embryos, in which blood and vessel development was severely repressed but cardiac markers were overexpressed. 30 Furthermore, in mouse embryos, it has been shown that the epiblast tissue maintains the hematopoietic potential during gastrulation, even after the period of hematopoietic differentiation is over and cardiac specification is initiated. 31 These observations support the notion that there is a biopotential or multipotential stage in early mesoderm and that activation of the cardiac program antagonizes the hematopoietic program. In the present study, we propose that Nkx2-5 has a dual role of promoting a cardiac fate and repressing hematopoietic fate in multipotent mesodermal progenitors. There is an apparent paradox with the previous report that hematopoiesis is impaired in Nkx2-5 mutant embryos. 5 We speculate that Nkx2-5 function is required in multiple stages of mesoderm development, and that the apparent lack of yolk sac hematopoiesis reflects an earlier function of Nkx2-5. 5, 32 With the ability to identify progenitor cell populations earlier during embryogenesis (E6.5 to E7.5), future studies will be aimed at defining the roles of Nkx2-5 in multiple stages of mesoderm development.
Using transcriptional assays, we showed that one of the targets of Nkx2-5 is the Gata1 gene, an essential transcription factor in erythroid differentiation. Gata1 expression is strongly suppressed in Nkx2-5-overexpressing ES cells, and overexpression of Gata1 rescued the inhibitory effect of Nkx2-5 on hematopoietic development. The region in the Gata1 minigene that is responsible for Nkx2-5-mediated repression coincided with G1HE. Although the absolute requirement of G1HE in erythroid transcription remains controversial, 33 G1HE maps with an erythroid-specific DNaseI-hypersensitive site and is required for expression of the Gata1 gene in primitive and definitive erythroid cells. 9 Mutation of the Gata binding site within G1HE severely impairs the promoter activity. Our chromatin immunoprecipitation assay and electrophoretic mobility shift assay demonstrated that Nkx2-5 binds to the G1HE region of the Gata1 gene. This region contained an evolutionarily conserved sequence that shows homology to the Nkx2-5 recognition sequence ( Figure 5A ). Further work is warranted to investigate the molecular nature of Nkx2-5-mediated transcriptional repression. It is interesting to note that Nkx2-5 not only activates transcription, but also can inhibit transcription. 34 Our findings suggest that hematopoietic genes are additional targets of the suppressive activity of Nkx2-5.
Conclusions
Our data have uncovered a novel biological function for Nkx2-5 that represses hematopoietic/erythroid but not the vascular potential of the mesodermal progenitors. These studies further enhance our understanding of the regulatory mechanisms that govern cardiac morphogenesis, and may contribute to regenerative pathways involving cardiac progenitor cell populations after injury of the adult heart.
